Results 151 to 160 of about 5,022,316 (352)
Migrainomics — identifying brain and genetic markers of migraine
D. Nyholt, D. Borsook, L. Griffiths
semanticscholar +1 more source
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source
An efficient protocol for in vitro propagation of Fig (Ficus carica sp) and evaluation of genetic fidelity using RAPD and ISSR markers [PDF]
Eldessoky S. Dessoky +2 more
openalex +1 more source
Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed +10 more
wiley +1 more source
Diabetic Charcot Neuroarthropathy: A Contemporary Review of Molecular and Genetic Markers. [PDF]
Narayan G, Panchbhavi VK.
europepmc +1 more source
ON ESTIMATING RELATEDNESS USING GENETIC MARKERS
G. Wilkinson, G. McCracken
semanticscholar +1 more source
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto +13 more
wiley +1 more source
Genetic predisposition markers for prostate cancer
Maria D Kanaeva, I. E. Orobtsova
openalex +2 more sources

